Hypertension and cardiovascular risk: General aspects
Abstract
Hypertension is the strongest or one of the strongest risk factors for almost all different cardiovascular diseases acquired during life, including coronary disease, left ventricular hypertrophy and valvular heart diseases, cardiac arrhythmias including atrial fibrillation, cerebral stroke and renal failure. The continuous relationship between blood pressure and cardiovascular and renal events makes the distinction between high normal blood pressure and hypertension based on arbitrary cut-off values for blood pressures. Overall the prevalence of hypertension in different European countries appears to be around 30-45% of the general population, with a steep increase with ageing. The prevention of cardiovascular disease and treatment recommendations should be related to quantification of total cardiovascular risk which could be estimated from several different models. However the impact of age on risk is so strong that young adults (particularly women) are unlikely to reach high-risk levels even when they have more than one major risk factor and a clear increase in relative risk. Therefore age-adjusted models, models assessing relative risks compared to others of same age and models including thorough assessments of target organ damage and ambulatory 24h blood pressure are needed together with national models because of the large variations between countries.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hypertension is the leading modifiable risk factor for cardiovascular disease, playing a central role in the development and progression of coronary artery disease in the general population.
“Hypertension is the leading modifiable risk factor for cardiovascular disease, playing a central role in the development and progression of CAD in the general population.12”
From Resting and exercise-induced occult hypertension and coronary atherosclerosis in male masters endurance athletes (2026) · cites this paper as [12]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 40 · Cited by 694
- Authors
- Kjeldsen, S. E.
- Affiliations
- Oslo University Hospital (NO)
- Corresponding author
- Kjeldsen, Sverre E.
- ORCID
- Kjeldsen, Sverre E.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 129
- Pages
- 95-99
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2767992133
- Cited by
- 694
- References
- 40
- Citations by year
- 2026: 47 · 2025: 105 · 2024: 132 · 2023: 124 · 2022: 96 · 2021: 79 · 2020: 69 · 2019: 33 · 2018: 9
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacological Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension, cardiovascular risk, cardiovascular disease, blood pressure, hypertension prevalence, age-related risk, cardiovascular risk prediction models, relative risk, target organ damage, ambulatory blood pressure, coronary disease, left ventricular hypertrophy, atrial fibrillation, stroke, renal failure, cardiovascular disease prevention
- MeSH terms
- Blood Pressure, Cardiovascular Diseases, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review